Reforming Pharmaceutical Industry-Physician Financial Relationships: Lessons from the United States, France, and Japan

Journal of Law, Medicine & Ethics 39 (4):662-670 (2011)
This article compares the means that the United States, France, and Japan use to oversee pharmaceutical industry-physician financial relationships. These countries rely on professional and/or industry ethical codes, anti-kickback laws, and fair trade practice laws. They restrict kickbacks the most strictly, allow wide latitude on gifts, and generally permit drug firms to fund professional activities and associations. Consequently, to avoid legal liability, drug firms often replace kickbacks with gifts and grants. The paper concludes by proposing reforms that address problems that persist when firms replace kickbacks with gifts and grants based on the experience of the three countries
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1111/j.1748-720X.2011.00633.x
 Save to my reading list
Follow the author(s)
Edit this record
My bibliography
Export citation
Find it on Scholar
Mark as duplicate
Request removal from index
Revision history
Download options
Our Archive

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 30,780
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library
References found in this work BETA

Add more references

Citations of this work BETA
Five Un-Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine & Ethics 41 (3):581-589.

Add more citations

Similar books and articles
Intellectual Property and Pharmaceutical Drugs.Richard T. de George - 2005 - Business Ethics Quarterly 15 (4):549-575.
Pharmaceutical “Gift-Giving,” Medical Education, and Conflict of Interest.Dale Murray & Heather Certain - 2007 - Journal of Philosophical Research 32 (Supplement):335-343.
Big Pharma: A Former Insider’s View. [REVIEW]David Badcott - 2013 - Medicine, Health Care and Philosophy 16 (2):249-264.
Added to PP index

Total downloads
14 ( #370,025 of 2,214,632 )

Recent downloads (6 months)
1 ( #408,824 of 2,214,632 )

How can I increase my downloads?

Monthly downloads
My notes
Sign in to use this feature